D-0790-2017 Class III Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0790-2017 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Mar 17, 2017 and is designated Class III. Reason for recall: Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate. The recall status is terminated (terminated Aug 24, 2021). Affected quantity: 7,776 tubes.

Recall details

Product Type
Drugs
Report Date
May 24, 2017
Initiation Date
Mar 17, 2017
Termination Date
Aug 24, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,776 tubes

Product description

Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3

Reason for recall

Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.

Distribution pattern

U.S. Nationwide

Code information

Lot #: D301311473, D301411473, Exp 3/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0790-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0790-2017. Report a data issue: hello@regdatalab.com.